ãžã§ã³ã»ããžã£ãŒã¹
ã¢ãªãšã«ã»ã€ã³ãã¹ãã¡ã³ã, LLC
ãžã§ã³ã»ããžã£ãŒã¹ã¯1983幎ã«ã¢ãªãšã«ã»ã€ã³ãã¹ãã¡ã³ããèšç«ããŸãããããžã£ãŒã¹ã¯å瀟ã®å°åæ ªããã³äžåæ ªã®æ©é¢æè³å®¶åãããŒããã©ãªãªããªãã³ã«ã¢ãªãšã«ã»ãã¡ã³ãïŒARGFXïŒãšã¢ãªãšã«ã»ã¢ãã¬ã·ãšãŒã·ã§ã³ã»ãã¡ã³ãïŒCAAPXïŒãéçšããŠããŸãããŸãããã©ãŒãã¹èªã§ãå¿è匷ãæè³å®¶ïŒPatient InvestorïŒããšããã³ã©ã ãé·æã«ãããå·çããŠããŸãã
ã»ã¯ã¿ãŒå¥é å
ã¬ãã«3ã»ã¯ã¿ãŒå¥å
èš³î®
ã¬ãã«1ã»ã¯ã¿ãŒå¥å
èš³
ã¬ãã«2ã»ã¯ã¿ãŒå¥å
èš³
ã¬ãã«3ã»ã¯ã¿ãŒå¥å
èš³
ããã« & ãšã³ã¿ãŒãã€ã³ã¡ã³ããµãŒãã¹
æè³éè¡ & æè³ãµãŒãã¹
ã¡ãã£ã¢ & åºç
å»çæ©åš & åå
æ©æ¢°ãå·¥å
·ã倧åè»äž¡ãéé & è¹è¶
ä¿éº
é»åæ©åš & éšå
å°é & 忥ãµãŒãã¹
äžåç£äºæ¥
éè¡ãµãŒãã¹
éä¿¡ & ãããã¯ãŒãã³ã°
ä»ã®
ä¿æéæ
2026Q2î®
2026Q2
2026Q1
2025Q4
2025Q3
2025Q2
2025Q1
çªå·
販売åç§°
ããŒããã©ãªãªã®ãŠã§ã€ã
ååŒæ ªåŒæ°
æäŸ¡ïŒæ¥ä»ïŒ
æäŸ¡ç·é¡
ä¿ææ ªåŒæ°
æ¥çš®
å ±åæ¥
ãŠã©ãããªã¹ã
4.28%
-802.83K
$428.94M
$428.94M
5.30M
ã¡ãã£ã¢ & åºç
2026-06-30
î
4.19%
-544.23K
$420.44M
$419.64M
14.89M
ããã« & ãšã³ã¿ãŒãã€ã³ã¡ã³ããµãŒãã¹
2026-06-30
î
Charles River Laboratories International Ord Shs (US) (US)
159864107
3.41%
+62.00K
$341.59M
--
1.51M
--
2026-06-30
î
3.37%
-64.35K
$338.29M
$338.28M
999.68K
æè³éè¡ & æè³ãµãŒãã¹
2026-06-30
î
3.25%
+769.37K
$325.75M
$325.75M
15.43M
ããã« & ãšã³ã¿ãŒãã€ã³ã¡ã³ããµãŒãã¹
2026-06-30
î
2.91%
-296.84K
$292.21M
$292.21M
997.95K
æ©æ¢°ãå·¥å
·ã倧åè»äž¡ãéé & è¹è¶
2026-06-30
î
2.87%
-796.98K
$288.15M
$288.15M
1.67M
ããã« & ãšã³ã¿ãŒãã€ã³ã¡ã³ããµãŒãã¹
2026-06-30
î
2.82%
+69.48K
$282.79M
$227.50M
1.64M
æ©æ¢°ãå·¥å
·ã倧åè»äž¡ãéé & è¹è¶
2026-06-30
î
2.64%
-58.79K
$264.63M
$264.63M
658.55K
ã¡ãã£ã¢ & åºç
2026-06-30
î

